84
H. Nambu et al. / Tetrahedron 59 (2003) 77–85
60.5, 73.5, 79.6, 113.7, 126.8, 135.0, 158.8, 172.3. 1H NMR
(CDCl3) cis-2f d: 1.26 (t, 3H, J¼7.0 Hz), 1.43–1.55 (m,
1H), 2.45–2.56 (m, 3H), 2.72–2.85 (m, 1H), 3.68–3.74 (m,
1H), 3.79 (s, 3H), 4.10–4.18 (m, 1H), 4.14 (q, 2H,
J¼7.0 Hz), 4.84 (dd, 1H, J¼6.5, 6.0 Hz), 6.87 (d, 2H,
J¼8.5 Hz), 7.24 (d, 2H, J¼8.5 Hz). 13C NMR (CDCl3) cis-
2f d: 14.2, 36.4, 38.1, 41.3, 55.2, 60.5, 73.1, 80.9, 113.7,
127.0, 135.0, 158.8, 172.3. HRMS (EI) calcd for C15H20O4
(Mþ): 264.1361. Found: 264.1368.
11.4, 27.6, 43.3, 76.5, 109.4, 120.2, 124.3, 128.0, 130.9,
159.9.
4.3.11. 1-(Methylsulfonyl)-4-methyl-2-(4-methoxy-
phenyl)pyrrolidine (2k). Obtained in 98% as diastereo-
meric mixture. Further purification of the diastereomers
using column chromatography was unsuccessful; colorless
1
needles: mp 105–1068C: IR (KBr) cm21: 1337, 1149. H
NMR (CDCl3) cis-2k d: 1.08 (d, 3H, J¼6.5 Hz), 1.55–1.67
(m, 1H), 2.24–2.38 (m, 1H), 2.44–2.58 (m, 1H), 2.54 (s,
3H), 3.04 (t, 1H, J¼10.5 Hz), 3.80 (s, 3H), 3.97 (dd, 1H,
J¼10.5, 8.5 Hz), 4.77 (dd, 1H, J¼10.0, 7.0 Hz), 6.88 (d, 2H,
J¼8.5 Hz), 7.28 (d, 2H, J¼8.5 Hz). 13C NMR (CDCl3) cis-
2k d: 16.4, 33.8, 39.2, 45.7, 55.2, 55.8, 63.9, 114.0, 128.0,
4.3.7. 3-Methyl-5-phenyloxolane (2g).23 Obtained in 87%
as diastereomeric mixture. Further purification of the
diastereomers using column chromatography was
1
unsuccessful; colorless oil: H NMR (CDCl3) trans-2g d:
1
1.09 (d, 3H, J¼7.0 Hz), 1.90–2.05 (m, 2H), 2.37–2.49 (m,
1H), 3.47 (dd, 1H, J¼8.0, 7.0 Hz), 4.22 (dd, 1H, J¼8.0,
7.0 Hz), 5.03 (t, 1H, J¼7.0 Hz), 7.20–7.36 (m, 5H). 13C
NMR (CDCl3) trans-2g d: 17.7, 33.2, 42.6, 75.7, 80.0,
125.5, 127.0, 128.2, 154.1. 1H NMR (CDCl3) cis-2g d: 1.09
(d, 3H, J¼7.0 Hz), 1.45 (dd, 1H, J¼9.5, 2.0 Hz), 2.40–2.55
(m, 2H), 3.58 (t, 1H, J¼8.0 Hz), 4.09 (t, 1H, J¼8.0 Hz),
4.92 (dd, 1H, J¼9.5, 6.0 Hz), 7.20–7.36 (m, 5H). 13C NMR
(CDCl3) cis-2g d: 17.3, 35.0, 43.9, 75.4, 81.6, 125.9, 127.0,
128.3, 154.1.
134.2, 159.0. H NMR (CDCl3) trans-2k d: 1.09 (d, 3H,
J¼6.5 Hz), 1.96–2.05 (m, 2H), 2.44–2.58 (m, 1H), 2.67 (s,
3H), 3.15 (t, 1H, J¼9.0 Hz), 3.70 (dd, 1H, J¼9.0, 6.5 Hz),
3.80 (s, 3H), 4.90 (dd, 1H, J¼6.5, 4.5 Hz), 6.88 (d, 2H,
J¼8.5 Hz), 7.28 (d, 2H, J¼8.5 Hz). 13C NMR (CDCl3)
trans-2k d: 17.1, 31.7, 38.1, 43.8, 55.2, 55.5, 62.3, 113.9,
127.4, 134.9, 158.8. HRMS (EI) calcd for C13H19NO3S
(Mþ): 269.1085. Found: 269.1091. Anal. calcd for
C13H19NO3S: C, 57.97; H, 7.11; N, 5.20; S, 11.90. Found:
C, 57.74; H, 6.96; N, 5.14; S, 11.80.
4.3.8.
7-Butyl-2,9-dioxabicyclo[4.3.0]nonane
(2h).
4.3.12. 4-Methyl-1-[(4-methylphenyl)sulfonyl]-2-(4-
methoxyphenyl)pyrrolidine (2l). Obtained in 88% as
diastereomeric mixture. Further purification of the dia-
stereomers using column chromatography was unsuccess-
Obtained in 98% as diastereomeric mixture. Further
purification of the diastereomers using column chromato-
graphy was unsuccessful; colorless oil: H NMR (CDCl3)
1
endo-2h d: 0.90 (t, 3H, J¼7.0 Hz), 1.10–1.50 (m, 6H),
1.50–1.99 (m, 5H), 2.20–2.39 (m, 1H), 3.38–3.56 (m, 1H),
3.57–3.79 (m, 2H), 3.94 (t, 1H, J¼8.0 Hz), 5.28 (d, 1H,
J¼3.0 Hz). 13C NMR (CDCl3) endo-2h d: 14.0, 19.2, 22.9,
ful; colorless needles: mp 103–1048C: IR (KBr) cm21
:
1346, 1159. 1H NMR (CDCl3) cis-2l d: 0.95 (d, 3H,
J¼6.5 Hz), 1.41–1.52 (m, 1H), 1.77–1.87 (m, 1H),
2.29–2.36 (m, 1H), 2.41 (s, 3H), 3.07 (t, 1H, J¼11.0 Hz),
3.78–3.84 (m, 1H), 3.79 (s, 3H), 4.58 (dd, 1H, J¼9.5,
7.0 Hz), 6.81 (d, 2H, J¼8.0 Hz), 7.22 (d, 2H, J¼8.0 Hz),
7.24 (d, 2H, J¼8.0 Hz), 7.59 (d, 2H, J¼8.0 Hz). 13C NMR
(CDCl3) cis-2l d: 16.5, 21.5, 33.2, 45.6, 55.3, 56.6, 64.2,
1
23.3, 26.7, 30.5, 36.5, 41.0, 61.0, 70.2, 102.1. H NMR
(CDCl3) exo-2h d: 0.90 (t, 3H, J¼7.0 Hz), 1.10–1.50 (m,
6H), 1.50–1.99 (m, 5H), 2.20–2.39 (m, 1H), 3.38–3.56 (m,
1H), 3.57–3.79 (m, 1H), 3.82–3.92 (m, 1H), 4.28 (t, 1H,
J¼8.0 Hz), 4.99 (d, 1H, J¼3.0 Hz). 13C NMR (CDCl3) exo-
2h d: 14.0, 20.8, 22.4, 22.9, 30.8, 32.4, 37.8, 44.2, 64.5,
74.3, 102.2. HRMS (FAB) calcd for C14H20O2 (MþþH):
185.1542. Found: 185.1525.
1
113.7, 127.4, 127.5, 129.5, 135.0, 135.7, 143.1, 158.7. H
NMR (CDCl3) trans-2l d: 0.87 (d, 3H, J¼6.5 Hz),
1.48–1.60 (m, 1H), 1.77–1.87 (m, 1H), 2.29–2.36 (m,
1H), 2.42 (s, 3H), 2.85 (t, 1H, J¼9.0 Hz), 3.72 (dd, 1H,
J¼9.0, 7.0 Hz), 3.79 (s, 3H), 4.79 (dd, 1H, J¼8.0, 2.5 Hz),
6.83 (d, 2H, J¼8.0 Hz), 7.22 (d, 2H, J¼8.0 Hz), 7.28 (d, 2H,
J¼8.0 Hz), 7.66 (d, 2H, J¼8.0 Hz). 13C NMR (CDCl3)
trans-2l d: 16.9, 21.5, 31.3, 43.5, 55.3, 55.8, 62.7, 113.6,
127.2, 127.5, 129.5, 135.0, 135.5, 143.2, 158.6. HRMS (EI)
calcd for C19H23NO3S (Mþ): 345.1398. Found: 345.1396.
Anal. calcd for C19H23NO3S: C, 66.06; H, 6.71; N, 4.05; S,
9.28. Found: C, 66.06; H, 6.72; N, 4.00; S, 9.21.
4.3.9. 3-Butyl-5-butoxyoxolane (2i).24 Obtained in 99% as
diastereomeric mixture. Further purification of the
diastereomers using column chromatography was
1
unsuccessful; colorless oil: H NMR (CDCl3) trans-2i d:
0.89 (t, 3H, J¼7.5 Hz), 0.92 (t, 3H, J¼7.5 Hz), 1.21–1.60
(m, 11H), 1.98–2.45 (m, 2H), 3.31–3.47 (m, 2H), 3.62–
3.71 (m, 1H), 3.94 (t, 1H, J¼7.5 Hz), 5.10 (dd, 1H, J¼5.5,
3.0 Hz). 13C NMR (CDCl3) trans-2i d: 13.9, 14.0, 19.4,
22.8, 30.9, 31.9, 32.8, 38.6, 39.1, 67.5, 71.9, 104.5. 1H NMR
(CDCl3) cis-2i d: 0.89 (t, 3H, J¼7.5 Hz), 0.92 (t, 3H,
J¼7.5 Hz), 1.21–1.60 (m, 11H), 1.98–2.45 (m, 2H), 3.31–
3.47 (m, 2H), 3.62–3.71 (m, 1H), 4.04 (t, 1H, J¼8.0 Hz),
5.10 (dd, 1H, J¼5.5, 3.0 Hz). 13C NMR (CDCl3) cis-2i d:
13.9, 14.0, 19.4, 22.8, 30.7, 31.8, 33.7, 37.0, 39.3, 67.0,
72.6, 104.1.
Acknowledgements
This work was supported by Grants-in-Aid for Scientific
Research (S) (No. 13853010), for Scientific Research on
Priority Area (A) (No. 13029062) from the Ministry of
Education, Science, Sports, and Culture, Japan and the
Takeda Science Foundation, Japan. We thank Wako Pure
Chemical Industries, Ltd., for the generous supply of several
water-soluble azo-type initiators. G. A. thanks the Japan
Society for the Promotion of Science (JSPS) for a
postdoctoral fellowship.
4.3.10. 3-Ethyloxaindane (2j).22 Obtained in 64% as
1
colorless oil: H NMR (CDCl3) d: 0.99 (t, 3H, J¼7.5 Hz),
1.56–1.69 (m, 1H), 1.75–1.86 (m, 1H), 3.33–3.43 (m, 1H),
4.23 (dd, 1H, J¼9.0, 6.5 Hz), 4.64 (t, 1H, J¼9.0 Hz), 6.78–
6.89 (m, 2H), 7.10–7.19 (m, 2H). 13C NMR (CDCl3) d: